Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001797917-26-000011

Director sold 575 shares at an average $10.83 ($6,230)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Prener Anne · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Sale : show line 1 in the form 10b5-1 −433 $10.77 $4,663 12,779 D
2026-11-17 Sale : show line 2 in the form 10b5-1 −142 $11.03 $1,566 12,637 D
Open-market sales · 575 sh · avg $10.83 · $6,230
Loading xslF345X06/form4-11192026_041101.xml…